Furthermore, in vivo liver metastasis assays demonstrated that CRC cells treated with anti-CXCL13 antibody or with knockdown of CXCR5 had reduced liver metastatic colonies compared to the control groups (Fig. 7g–i and Additional file 12: Fig. S12). This evidence concerns the gene CXCR5 and colorectal carcinoma.